Correlation Between Eliem Therapeutics and Seelos Therapeutics
Can any of the company-specific risk be diversified away by investing in both Eliem Therapeutics and Seelos Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eliem Therapeutics and Seelos Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eliem Therapeutics and Seelos Therapeutics, you can compare the effects of market volatilities on Eliem Therapeutics and Seelos Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eliem Therapeutics with a short position of Seelos Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eliem Therapeutics and Seelos Therapeutics.
Diversification Opportunities for Eliem Therapeutics and Seelos Therapeutics
0.67 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Eliem and Seelos is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Eliem Therapeutics and Seelos Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Seelos Therapeutics and Eliem Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eliem Therapeutics are associated (or correlated) with Seelos Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Seelos Therapeutics has no effect on the direction of Eliem Therapeutics i.e., Eliem Therapeutics and Seelos Therapeutics go up and down completely randomly.
Pair Corralation between Eliem Therapeutics and Seelos Therapeutics
Given the investment horizon of 90 days Eliem Therapeutics is expected to generate 0.42 times more return on investment than Seelos Therapeutics. However, Eliem Therapeutics is 2.39 times less risky than Seelos Therapeutics. It trades about -0.29 of its potential returns per unit of risk. Seelos Therapeutics is currently generating about -0.5 per unit of risk. If you would invest 411.00 in Eliem Therapeutics on August 29, 2024 and sell it today you would lose (111.00) from holding Eliem Therapeutics or give up 27.01% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 85.0% |
| Values | Daily Returns |
Eliem Therapeutics vs. Seelos Therapeutics
Performance |
| Timeline |
| Eliem Therapeutics |
| Seelos Therapeutics |
Eliem Therapeutics and Seelos Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eliem Therapeutics and Seelos Therapeutics
The main advantage of trading using opposite Eliem Therapeutics and Seelos Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eliem Therapeutics position performs unexpectedly, Seelos Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Seelos Therapeutics will offset losses from the drop in Seelos Therapeutics' long position.| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
| Seelos Therapeutics vs. Rezolute | Seelos Therapeutics vs. Tempest Therapeutics | Seelos Therapeutics vs. Forte Biosciences | Seelos Therapeutics vs. Dyadic International |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |